New York Life Investment Management LLC Purchases 603 Shares of Intuitive Surgical, Inc. $ISRG

New York Life Investment Management LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.1% in the second quarter, HoldingsChannel.com reports. The firm owned 53,706 shares of the medical equipment provider’s stock after acquiring an additional 603 shares during the period. New York Life Investment Management LLC’s holdings in Intuitive Surgical were worth $29,184,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of ISRG. Norway Savings Bank grew its stake in Intuitive Surgical by 53.4% during the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after acquiring an additional 910 shares in the last quarter. IronOak Wealth LLC. purchased a new position in Intuitive Surgical during the second quarter valued at $1,099,000. Trust Co. of Oklahoma purchased a new position in Intuitive Surgical during the second quarter valued at $363,000. Neville Rodie & Shaw Inc. grew its stake in Intuitive Surgical by 11.9% during the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after acquiring an additional 1,110 shares in the last quarter. Finally, Bessemer Group Inc. grew its stake in Intuitive Surgical by 89.3% during the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock valued at $428,386,000 after acquiring an additional 371,806 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Trading Up 0.9%

Shares of ISRG opened at $551.25 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a market cap of $197.61 billion, a P/E ratio of 72.92, a P/E/G ratio of 5.02 and a beta of 1.61. The company’s fifty day simple moving average is $459.49 and its 200-day simple moving average is $497.31.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.84 earnings per share. Analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Craig H. Barratt sold 2,193 shares of the firm’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $548.01, for a total transaction of $1,201,785.93. The disclosure for this sale can be found here. Over the last quarter, insiders sold 88,324 shares of company stock worth $46,093,939. 0.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on ISRG. Truist Financial set a $620.00 target price on shares of Intuitive Surgical and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Sunday. Finally, Evercore ISI decreased their price target on shares of Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 7th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $603.38.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.